Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11805734 | PMC |
| http://dx.doi.org/10.1186/s43556-025-00245-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development of smartphone-based AIE fluorescence-quenching immunochromatographic sensors for the detection of illicit drugs in various complex sample matrices.
Anal Bioanal Chem
September 2025
GuangDong Engineering Technology Research Center of Antibody Drug and Immunoassay, Department of Biological Sciences and Biotechnology, College of Life Science and Technology, Jinan University, Guangzhou, 510632, China.
Illicit drug abuse poses a significant global threat to public health and social security, highlighting the urgent need for rapid, sensitive, and versatile detection technologies. To address the limitations of traditional chromatographic techniques-such as high costs and slow response times-and the drawbacks of conventional immunochromatographic sensors (ICS), including low sensitivity and non-intuitive signal outputs, a fluorescence-quenching ICS (FQICS) was developed. This sensor leverages fluorescence resonance energy transfer (FRET) between aggregation-induced emission fluorescent microspheres (AIEFMs) and gold nanoparticles (AuNPs).
View Article and Find Full Text PDFAcute kidney injury and subsequent risk of late-onset infection among extremely low gestational age newborns.
J Perinatol
September 2025
University of Colorado School of Medicine, Department of Pediatrics, Aurora, CO, USA.
Objective: Determine whether acute kidney injury (AKI) is associated with subsequent late-onset infection (LOI) among extremely low gestational age newborns (ELGAN).
Study Design: Secondary analysis of participants in the Preterm Erythropoietin for Neuroprotection Trial. Infants surviving ≥7 days with sufficient serum creatinine data were included.
Pediatric urinary health and school health conditions in France: A political urgency?
J Pediatr Urol
August 2025
School of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, TSA 51115, 86073, Poitiers Cedex, France; Clinical Investigation Center, INSERM, 2 Rue de la Milétrie 1402, 86021, Poitiers, France; University of Poitiers, CNRS UMR7267, Ecologie & Biologie des Interactions, 86000, Poi
Purpose: The high frequency of urinary disorders and their complications among school-aged children is common but few studies have investigated their predictors such as poor urinary hygiene habits, inappropriate use of school toilets, and deteriorated school toilets conditions. The question is whether individual factors (behaviors) conditioned by environmental factors (toilet conditions) play a role in functional urinary disorders.
Materials And Methods: We performed an electronic cross-sectional observational study from October 1, 2023, to March 31, 2024, in the department of Vienne (France), among children's parents.
Investigating the Relationship Between Mutations in and Genes and Resistance to Fluoroquinolones in Uropathogenic Isolates.
Microb Drug Resist
September 2025
Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R. Iran.
Fluoroquinolone resistance in , particularly uropathogenic (UPEC), is a growing concern worldwide. This study investigates the association between mutations in the and genes and fluoroquinolone resistance in UPEC isolates from Urine samples in Iran. In total, 150 UPEC isolates were collected, and then, 12 ciprofloxacin-resistant isolates were selected for molecular analysis.
View Article and Find Full Text PDFQuantification of fluvoxamine, desmethyl fluvoxamine and fluvoxamine acid by LC-MS/MS in body fluids and solid tissues obtained from a deceased using the standard addition method.
Leg Med (Tokyo)
August 2025
Department of Legal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu 431-3192, Japan.
Reports on the quantification of fluvoxamine (FLV) in human tissues have been quite limited, although FLV has been used as an antidepressant since 1986. Fluvoxamine acid (FLA) was shown to be the major metabolite of FLV in human urine in 1983, but its quantification is also limited to only three works using human plasma. The existence of desmethyl fluvoxamine (FLD) in human specimens was recently reported in 2025; therefore, its quantification has not yet been performed.
View Article and Find Full Text PDF